Neumora Therapeutics IncNASDAQ:NMRA
- LAST PRICE13.0800
- TODAY'S CHANGE (%)0.2800 (2.1875%)
- Bid / Lots12.5600/ 3
- Ask / Lots13.5000/ 100
- Open / Previous Close12.9900 / 12.8000
- Day Range
- 52 Week Range
- Volume536,759
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NMRA |
|---|---|---|
| 09:32 ET | 2704 | 12.865 |
| 09:34 ET | 3900 | 12.53 |
| 09:36 ET | 1500 | 12.7 |
| 09:38 ET | 1725 | 12.77 |
| 09:45 ET | 100 | 12.71 |
| 09:50 ET | 1513 | 12.77 |
| 09:52 ET | 600 | 12.7212 |
| 09:54 ET | 541 | 12.72 |
| 09:56 ET | 800 | 12.61 |
| 09:57 ET | 300 | 12.61 |
| 09:59 ET | 4322 | 12.76 |
| 10:01 ET | 5501 | 12.845 |
| 10:03 ET | 3370 | 12.87 |
| 10:06 ET | 3839 | 12.935 |
| 10:08 ET | 1550 | 12.86 |
| 10:10 ET | 2057 | 12.85 |
| 10:12 ET | 1430 | 12.89 |
| 10:14 ET | 58741 | 12.98 |
| 10:15 ET | 30745 | 13.09 |
| 10:17 ET | 1604 | 12.97 |
| 10:19 ET | 2687 | 13.13 |
| 10:21 ET | 1103 | 13.2 |
| 10:24 ET | 3397 | 13.2 |
| 10:26 ET | 3468 | 13.135 |
| 10:28 ET | 2811 | 13.06 |
| 10:30 ET | 758 | 13.02 |
| 10:32 ET | 804 | 13.025 |
| 10:33 ET | 100 | 13.01 |
| 10:35 ET | 335 | 13.02 |
| 10:37 ET | 1400 | 13.06 |
| 10:39 ET | 631 | 13.08 |
| 10:42 ET | 1719 | 13.085 |
| 10:44 ET | 900 | 13.01 |
| 10:46 ET | 800 | 12.96 |
| 10:48 ET | 6226 | 13.05 |
| 10:50 ET | 169 | 13.01 |
| 10:51 ET | 100 | 13.03 |
| 10:53 ET | 1379 | 13.02 |
| 10:55 ET | 100 | 12.96 |
| 10:57 ET | 462 | 12.97 |
| 11:00 ET | 1062 | 12.93 |
| 11:02 ET | 989 | 12.91 |
| 11:04 ET | 372 | 12.89 |
| 11:06 ET | 100 | 12.89 |
| 11:08 ET | 1200 | 12.93 |
| 11:09 ET | 1300 | 12.99 |
| 11:11 ET | 150 | 13.0032 |
| 11:13 ET | 909 | 13.01 |
| 11:15 ET | 100 | 13 |
| 11:18 ET | 200 | 13.02 |
| 11:20 ET | 100 | 12.99 |
| 11:22 ET | 2279 | 13.03 |
| 11:24 ET | 1100 | 13.02 |
| 11:26 ET | 200 | 13.035 |
| 11:27 ET | 600 | 13.02 |
| 11:29 ET | 309 | 13.01 |
| 11:31 ET | 500 | 13.04 |
| 11:33 ET | 100 | 13.03 |
| 11:36 ET | 200 | 13.03 |
| 11:38 ET | 450 | 13.015 |
| 11:40 ET | 1954 | 13.05 |
| 11:42 ET | 794 | 13.08 |
| 11:44 ET | 200 | 13.09 |
| 11:45 ET | 1470 | 13.13 |
| 11:47 ET | 100 | 13.15 |
| 11:49 ET | 200 | 13.14 |
| 11:51 ET | 200 | 13.14 |
| 11:54 ET | 5400 | 13.12 |
| 12:00 ET | 1564 | 13.145 |
| 12:02 ET | 1072 | 13.18 |
| 12:03 ET | 100 | 13.14 |
| 12:09 ET | 3460 | 13.21 |
| 12:12 ET | 866 | 13.225 |
| 12:16 ET | 200 | 13.22 |
| 12:18 ET | 450 | 13.2 |
| 12:20 ET | 1380 | 13.24 |
| 12:21 ET | 623 | 13.245 |
| 12:23 ET | 250 | 13.23 |
| 12:25 ET | 1005 | 13.22 |
| 12:27 ET | 600 | 13.23 |
| 12:30 ET | 100 | 13.21 |
| 12:32 ET | 1220 | 13.165 |
| 12:34 ET | 500 | 13.18 |
| 12:36 ET | 265 | 13.19 |
| 12:38 ET | 13079 | 13.18 |
| 12:39 ET | 300 | 13.18 |
| 12:41 ET | 1400 | 13.18 |
| 12:43 ET | 200 | 13.17 |
| 12:48 ET | 100 | 13.185 |
| 12:50 ET | 100 | 13.17 |
| 12:52 ET | 3601 | 13.16 |
| 12:54 ET | 251 | 13.16 |
| 12:56 ET | 1500 | 13.09 |
| 12:59 ET | 450 | 13.04 |
| 01:01 ET | 100 | 13.04 |
| 01:03 ET | 650 | 13.05 |
| 01:06 ET | 900 | 13.07 |
| 01:08 ET | 250 | 13.04 |
| 01:10 ET | 950 | 13.045 |
| 01:14 ET | 547 | 13.01 |
| 01:17 ET | 1900 | 12.99 |
| 01:19 ET | 500 | 12.96 |
| 01:24 ET | 961 | 12.93 |
| 01:26 ET | 100 | 12.91 |
| 01:28 ET | 500 | 12.89 |
| 01:30 ET | 302 | 12.92 |
| 01:32 ET | 1112 | 12.9446 |
| 01:35 ET | 3185 | 12.96 |
| 01:37 ET | 302 | 12.96 |
| 01:39 ET | 700 | 12.97 |
| 01:42 ET | 850 | 12.97 |
| 01:44 ET | 810 | 12.96 |
| 01:48 ET | 200 | 12.98 |
| 01:50 ET | 674 | 12.976 |
| 01:51 ET | 100 | 12.975 |
| 01:53 ET | 1100 | 12.99 |
| 01:55 ET | 100 | 13.02 |
| 01:57 ET | 757 | 13.005 |
| 02:00 ET | 100 | 13.02 |
| 02:04 ET | 239 | 13.015 |
| 02:08 ET | 244 | 13.015 |
| 02:09 ET | 400 | 13 |
| 02:11 ET | 500 | 13 |
| 02:13 ET | 900 | 13 |
| 02:15 ET | 350 | 13.01 |
| 02:20 ET | 800 | 13.03 |
| 02:24 ET | 400 | 13.05 |
| 02:29 ET | 1305 | 13.05 |
| 02:31 ET | 850 | 13.035 |
| 02:33 ET | 350 | 13.02 |
| 02:36 ET | 105 | 13.0276 |
| 02:38 ET | 701 | 13.02 |
| 02:40 ET | 8512 | 13 |
| 02:44 ET | 300 | 12.99 |
| 02:45 ET | 315 | 13 |
| 02:47 ET | 1272 | 13 |
| 02:49 ET | 3582 | 12.99 |
| 02:51 ET | 100 | 12.995 |
| 02:54 ET | 100 | 12.96 |
| 02:56 ET | 100 | 12.99 |
| 02:58 ET | 700 | 13 |
| 03:00 ET | 300 | 13.02 |
| 03:02 ET | 350 | 13.02 |
| 03:03 ET | 600 | 13.04 |
| 03:05 ET | 317 | 13.059 |
| 03:09 ET | 500 | 13.065 |
| 03:12 ET | 200 | 13.07 |
| 03:14 ET | 601 | 13.06 |
| 03:16 ET | 750 | 13.075 |
| 03:18 ET | 400 | 13.08 |
| 03:20 ET | 200 | 13.05 |
| 03:21 ET | 2029 | 13.04 |
| 03:23 ET | 1756 | 12.98 |
| 03:25 ET | 207 | 12.99 |
| 03:30 ET | 850 | 13.01 |
| 03:32 ET | 250 | 13 |
| 03:34 ET | 3430 | 13.05 |
| 03:36 ET | 100 | 13.08 |
| 03:38 ET | 450 | 13.075 |
| 03:39 ET | 150 | 13.07 |
| 03:41 ET | 742 | 13.11 |
| 03:43 ET | 30055 | 13.21 |
| 03:45 ET | 200 | 13.18 |
| 03:48 ET | 659 | 13.195 |
| 03:50 ET | 3938 | 13.23 |
| 03:52 ET | 1700 | 13.2 |
| 03:54 ET | 1017 | 13.2 |
| 03:56 ET | 7001 | 13.14 |
| 03:57 ET | 10174 | 13.145 |
| 03:59 ET | 82035 | 13.08 |
Sep 12, 2024
DJ Neumora Therapeutics Price Target Maintained With a $23.00/Share by Needham, from 1:41PM ET on Thursday Sep 12, 2024 by Dow Jones
1:41PM ET on Thursday Sep 12, 2024 by Dow Jones
Sep 4, 2024
DJ Neumora Therapeutics Price Target Maintained With a $29.00/Share by RBC Capital, from 10:06AM ET on Wednesday Sep 04, 2024 by Dow Jones
10:06AM ET on Wednesday Sep 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Neumora Therapeutics Inc | 2.0B | -7.9x | --- |
Keros Therapeutics Inc | 2.1B | -11.1x | --- |
Akero Therapeutics Inc | 1.9B | -8.6x | --- |
Centessa Pharmaceuticals PLC | 2.0B | -10.1x | --- |
Soleno Therapeutics Inc | 1.9B | -20.0x | --- |
Verona Pharma PLC | 2.3B | -17.8x | --- |
Company Information
Neumora Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company’s therapeutic pipeline consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its advanced product candidate, navacaprant (NMRA-140), is a novel once-daily oral kappa opioid receptor (KOR) antagonist that is being developed for the treatment of depressive disorder (MDD). Its other candidates include NMRA-266, NMRA-511, and NMRA-NMDA. NMRA-266 is a positive allosteric modulator program of the M4 muscarinic receptor (M4R) for the treatment of schizophrenia. NMRA-266 is designed to be selective for the M4 receptor subtype of the muscarinic receptor family. NMRA-511 is an investigational antagonist of the vasopressin 1a receptor (V1aR). NMRA-NMDA is an NMDA positive allosteric modulator program that the Company is developing for the treatment of schizophrenia.
Contact Information
- Headquarters
- 490 Arsenal Way, Suite 200WATERTOWN, MA, United States 02472
- Phone
- 857-760-0900
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board, Co-Founder
- Paul Berns
- President, Chief Executive Officer, Director
- Henry Gosebruch
- Co-Founder, Chief Operating Officer
- Carol Suh
- Chief Financial Officer
- Joshua Pinto
- Chief Strategy Officer
- Daljit Aurora
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.0B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 160.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.66 |
Book Value | $2.95 |
P/E Ratio | -7.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
